I think for current IPF investors it is more meaningful to focus on whats going on now. Roche is testing Pirfenidone with their former IL-13 drug (they kept ILD rights) https://clinicaltrials.gov/ct2/show/NCT01872689
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.